Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer

SIMPLE SUMMARY: The addition of chromosome 17 polysomy/HER2 amplification status to the updated EAU and AUA scores improves their accuracy, allowing molecular reclassification of EAU high-risk NMIBCs and G2 tumors. Based on this, we propose to reclassify the non-HER2 amplified, non-polysomic EAU 3–4...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocsmár, Ildikó, Kocsmár, Éva, Pajor, Gábor, Kulka, Janina, Székely, Eszter, Kristiansen, Glen, Schilling, Oliver, Nyirády, Péter, Kiss, András, Schaff, Zsuzsa, Riesz, Péter, Lotz, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558547/
https://www.ncbi.nlm.nih.gov/pubmed/36230493
http://dx.doi.org/10.3390/cancers14194570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558547/
https://www.ncbi.nlm.nih.gov/pubmed/36230493
http://dx.doi.org/10.3390/cancers14194570

Ejemplares similares